Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2018

Open Access 01-12-2018 | Study protocol

SEALIVE: the use of technical vessel-sealing devices for recipient hepatectomy in liver transplantation: study protocol for a randomized controlled trial

Authors: Philipp Houben, Elias Khajeh, Ulf Hinz, Phillip Knebel, Markus K. Diener, Arianeb Mehrabi

Published in: Trials | Issue 1/2018

Login to get access

Abstract

Background

The surgical technique used in liver transplantation has undergone constant evolution in an effort to develop a safe, highly standardized procedure. Despite this, the initial step of recipient hepatectomy has not been the focus of clinical research thus far. Due to advanced coagulopathy in liver transplant recipients, this part of the operation still carries the risk of severe hemorrhage. This trial is designed to compare an electrothermal bipolar vessel sealing device (LigaSure™) and an ultrasound dissector (HARMONIC ACE®+7) with standard surgical techniques during the recipients’ hepatectomy in liver transplantation.

Methods/design

In a single-center, prospective, randomized, controlled, parallel, three-armed, confirmatory, open trial, LigaSure™ and HARMONIC ACE®+7 will be compared with standard surgical techniques that use titanium clips and conventional knot-tying ligations during recipient hepatectomy in liver transplantation. Intraoperative total blood loss is the primary endpoint of the trial. Secondary endpoints include blood loss during hepatectomy, the duration of both the hepatectomy and the entire surgical procedure, and blood transfusion requirements of the procedure. To generate reliable data, intraoperative blood loss will be recorded with respect to all rinse fluids during surgery, ascites, and by weighing used swabs. At 80% power and an alpha of 0.025 for both of the experimental groups, 23 subjects will be analyzed per protocol in each study arm in order to detect clinically relevant reduction of intraoperative blood loss. The intention-to-treat analysis will include 69 patients. The follow-up period for each patient will be 90 days for safety reasons, whereas all clinical outcomes will be measured within the first 10 postoperative days.

Discussion

To our knowledge, this is the first prospective, randomized trial comparing two innovative technical methods of vessel sealing and dissection with standard techniques for recipient hepatectomy. This will be done to detect relevant reduction of intraoperative blood loss during liver transplant. The results of the trial are expected to improve patient outcome and safety after liver transplant and to increase the general safety of this procedure.

Trial registration

ClinicalTrials.gov, NCT 03323242. Registered on October 26, 2017.
Appendix
Available only for authorised users
Literature
1.
Calne R, McMaster P, Smith D, et al. Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet. 1979;314:612–4.CrossRef
2.
Shaw BW Jr. Some further notes on venous bypass for orthotopic transplantation of the liver. Transplant Proc. 1987;19(4 Suppl 3):13–6.PubMed
3.
4.
Belghiti J, Panis Y, Sauvanet A, et al. A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion. Surg Gynecol Obstet. 1992;175:270–2.PubMed
5.
Hoffmann K, Hinz U, Hillebrand N, et al. Risk factors of survival after liver transplantation for HCC: a multivariate single-center analysis. Clin Transpl. 2011;25:E541–51.CrossRef
6.
Qian NS, Liao YH, Cai SW, et al. Comprehensive application of modern technologies in precise liver resection. Hepatob Pancreat Dis Int. 2013;12:244–50.CrossRef
7.
Amaral JF. The experimental development of an ultrasonically activated scalpel for laparoscopic use. Surg Laparosc Endosc Percut Techn. 1994;4:92–9.
8.
Rees M, Plant G, Wells J, Bygrave S. One hundred and fifty hepatic resections: evolution of technique towards bloodless surgery. Br J Surg. 1996;83:1526–9.CrossRefPubMed
9.
Abbasoglu O, Sayek I. Parenchymal transection with ultrasonic scalpel in liver resection. HPB (Oxford). 2003;5:167–9.CrossRef
10.
Olmez A, Karabulut K, Aydin C, et al. Comparison of harmonic scalpel versus conventional knot tying for transection of short hepatic veins at liver transplantation: prospective randomized study. Transplant Proc. 2012;44:1717–9.CrossRefPubMed
11.
Houben P, Buchler MW, Schemmer P. Use of an electrothermal bipolar vessel sealing device during recipient hepatectomy for liver transplantation. J Am Coll Surg. 2014;219:e59–63.CrossRefPubMed
12.
Lamattina JC, Hosseini M, Fayek SA, et al. Efficiency of the LigaSure vessel sealing system for recipient hepatectomy in liver transplantation. Transplant Proc. 2013;45:1931–3.CrossRefPubMed
13.
Arru M, Pulitano C, Aldrighetti L, et al. A prospective evaluation of ultrasonic dissector plus harmonic scalpel in liver resection. Am Surg. 2007;73:256–60.PubMed
14.
Cheang T, Hanna SS, Wright FC, Law CH. Use of a collagen-sealing device in hepatic resection: a comparative analysis to standard resection technique. HPB (Oxford). 2006;8:194–9.CrossRef
15.
Doklestic K, Karamarkovic A, Stefanovic B, et al. The efficacy of three transection techniques of the liver resection: a randomized clinical trial. Hepatogastroenterology. 2012;59:1501–6.PubMed
16.
Ikeda M, Hasegawa K, Sano K, et al. The vessel sealing system (LigaSure) in hepatic resection: a randomized controlled trial. Ann Surg. 2009;250:199–203.CrossRefPubMed
17.
Nanashima A, Abo T, Arai J, et al. Usefulness of vessel-sealing devices combined with crush clamping method for hepatectomy: a retrospective cohort study. Int J Surg. 2013;11:891–7.CrossRefPubMed
18.
Saiura A, Yamamoto J, Koga R, et al. Liver transection using the LigaSure sealing system. HPB (Oxford). 2008;10:239–43.CrossRef
19.
Savlid M, Strand AH, Jansson A, et al. Transection of the liver parenchyma with an ultrasound dissector or a stapler device: results of a randomized clinical study. World J Surg. 2013;37:799–805.CrossRefPubMed
20.
Yoshimoto M, Endo K, Hanaki T, et al. Effectiveness of the LigaSure small jaw vessel-sealing system in hepatic resection. Yonago Acta Med. 2014;57:93–8.PubMedPubMedCentral
21.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral
22.
Mangus RS, Kinsella SB, Nobari MM, et al. Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique. Transplant Proc. 2007;39:3207–13.CrossRefPubMed
23.
Massicotte L, Denault AY, Beaulieu D, et al. Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center. Transplantation. 2012;93:1276–81.CrossRefPubMed
24.
Hendriks H, van der Meer J, de Wolf JTM, et al. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int. 2005;17:673–9.CrossRefPubMed
25.
Janssen PF, Brölmann HA, Huirne JA. Effectiveness of electrothermal bipolar vessel-sealing devices versus other electrothermal and ultrasonic devices for abdominal surgical hemostasis: a systematic review. Surg Endosc. 2012;26:2892–901.CrossRefPubMed
26.
Mehrabi A, Mood ZA, Fonouni H, et al. A single-center experience of 500 liver transplants using the modified piggyback technique by Belghiti. Liver Transpl. 2009;15:466–74.CrossRefPubMed
27.
Mieth M, Schemmer P, Encke J, et al. Heidelberger Manual der Lebertransplantation. 2nd ed. Heidelberg: Universitatsklinikum Heidelberg; 2006.
28.
Rana A, Petrowsky H, Hong JC, Agopian VG, Kaldas FM, Farmer D, et al. Blood transfusion requirement during liver transplantation is an important risk factor for mortality. J Am Coll Surg. 2013;216:902–7.CrossRefPubMed
29.
Cleland S, Corredor C, Ye JJ, Srinivas C, McCluskey SA. Massive haemorrhage in liver transplantation: consequences, prediction and management. World J Transplant. 2016;6:291–305.CrossRefPubMedPubMedCentral
30.
Wehry J, Cannon R, Scoggins CR, Puffer L, McMasters KM, Martin RCG. Restrictive blood transfusion protocol in liver resection patients reduces blood transfusions with no increase in patient morbidity. Am J Surg. 2015;209:280–8.CrossRefPubMed
31.
Massicotte L, Sassine MP, Lenis S, Seal RF, Roy A. Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth. 2005;52:148–55.CrossRefPubMed
32.
Boin IFSF, Leonardi MI, Luzo ACM, Cardoso AR, Caruy CA, Leonardi LS. Intraoperative massive transfusion decreases survival after liver transplantation. Transplant Proc. 2008;40:789–91.CrossRefPubMed
33.
Moher D, Schulz KF, Altman D, CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285:1987–91.CrossRefPubMed
34.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–7.CrossRefPubMedPubMedCentral
Metadata
Title
SEALIVE: the use of technical vessel-sealing devices for recipient hepatectomy in liver transplantation: study protocol for a randomized controlled trial
Authors
Philipp Houben
Elias Khajeh
Ulf Hinz
Phillip Knebel
Markus K. Diener
Arianeb Mehrabi
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Trials / Issue 1/2018
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-018-2778-1

Other articles of this Issue 1/2018

Trials 1/2018 Go to the issue

Study protocol

Efficacy and safety of electroacupuncture for post stroke depression: study protocol for a randomized controlled trial

Correction

Correction to: Intrauterine resuscitation during the second stage of term labour by maternal hyperoxygenation versus conventional care: study protocol for a randomised controlled trial (INTEREST O2)

Study protocol

Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol

Study protocol

Telerehabilitation for aphasia – protocol of a pragmatic, exploratory, pilot randomized controlled trial

Study protocol

Evaluating interventions for informed consent for surgery (ICONS): Protocol for the development of a core outcome set

Study protocol

Controlling Hypertension After Severe Cerebrovascular Event (CHASE): study protocol for a randomized controlled trial